Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-18

Clinical Trial Update: Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated pemetrexed disodium and cisplatin followed by surgery and radiation therapy for malignant pleural mesothelioma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alimta (pemetrexed)
  • CISPLATIN (cisplatin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Malignant Mesothelioma | Phase 2 | Status: COMPLETED